Alnajashi, H. 2025. Ocrelizumab and Rituximab for the Treatment of Multiple Sclerosis Patients: A Real-World Clinical Experience: Comparing Ocrelizumab and Rituximab in MS Treatment. Journal of Contemporary Medical Sciences. 11, 4 (Aug. 2025). DOI:https://doi.org/10.22317/jcms.v11i4.1916.